AI Article Synopsis

  • The study investigates the structure-activity relationship of potent ergoline compounds that selectively inhibit the CXCR3 receptor, achieving IC(50) values under 10nM in specific assays.
  • Introduction of polar substituents improved activity in receptor occupancy assays, leading to more effective compounds.
  • Compound 11a emerged as a particularly promising candidate due to its favorable pharmacokinetics and cross-reactivity with rodent CXCR3, which could be useful in animal studies.

Article Abstract

The structure-activity relationship of highly potent special ergolines which selectively block the chemokine receptor CXCR3 is reported. The most potent compounds showed IC(50) values below 10nM in both ligand binding and Ca(2+)-mobilization assays. However, these compounds were poorly active in an assay that measures receptor occupancy in blood. Introduction of polar substituents led to derivatives with IC(50) values below 10nM in this assay. Among them was compound 11a which showed both a favorable PK profile and cross reactivity with rodent CXCR3 making it a promising tool compound to further explore the role of CXCR3 in animal models.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2011.06.070DOI Listing

Publication Analysis

Top Keywords

special ergolines
8
chemokine receptor
8
receptor cxcr3
8
ic50 values
8
values 10nm
8
ergolines efficiently
4
efficiently inhibit
4
inhibit chemokine
4
cxcr3
4
cxcr3 blood
4

Similar Publications

Rationale: Peliosis hepatis (PH) is a rare disease with few clinical reports and complex etiology. However, there have been no reports of hyperprolactinemia (HPRL) leading to PH at present. This paper, through case reports, expands the understanding of the etiology of PH and the pathological damage effect of prolactin (PRL).

View Article and Find Full Text PDF

Molecular regulatory effect of the ergot alkaloid methylergometrine on the α3β4 nicotinic acetylcholine receptor.

Biochem Biophys Res Commun

January 2025

Department of Biotechnology and Department of Integrative Food, Bioscience and Biotechnology (BK21 FOUR), Chonnam National University, Gwangju, 61186, South Korea. Electronic address:

Methylergometrine has widely been used pharmacologically to treat conditions such as pain, addiction, vasoconstriction, migraines, and Parkinson's disease. Despite its side effects, it is used as a therapeutic agent and research material for various diseases based on its natural potential; however, the regulatory effect of its interaction with the nicotinic acetylcholine receptor (nAChR) has not yet been investigated. The α3β4 nAChR is an ion channel essential for neurotransmission within the sympathetic, parasympathetic, and autonomic nervous systems.

View Article and Find Full Text PDF

Background: Giant prolactinoma (size > 4 cm) is a rare condition and accounts for less than 1% of pituitary adenomas. In even rarer cases, these lesions may involve craniocervical structures requiring surgical intervention. The present case is the largest reported giant prolactinoma (99 × 72 × 57 mm).

View Article and Find Full Text PDF

Forensic Aspects of Designer LSD Analogs Identification by GC-MS (EI) and UV Spectroscopy.

Molecules

December 2024

Department of Forensic Medicine, Wroclaw Medical University, 4 J. Mikulicza-Radeckiego Street, 50-345 Wroclaw, Poland.

Article Synopsis
  • LSD analogs are emerging psychoactive substances designed to mimic illegal drugs while bypassing regulations, presenting identification challenges due to their diverse isomeric forms.
  • Gas chromatography-mass spectrometry (GC-MS) and UV spectroscopy were utilized to analyze 13 different LSD analogs, revealing that specific solvents enhanced detection sensitivity, while methanol could produce misleading results.
  • The study successfully established a method for distinguishing between LSD analogs and their isomers through unique ion fragmentation patterns and intensities, aiding in accurate forensic analysis.
View Article and Find Full Text PDF

A comparative study of effects of DOM and lisuride on neuronal activity in nucleus accumbens of freely moving rats.

Eur J Pharmacol

January 2025

State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Key Laboratory of Neuropsychopharmacology, Beijing Institute of Pharmacology and Toxicology, 27th Taiping Road, 100850, Beijing, China. Electronic address:

Article Synopsis
  • DOM and lisuride are both chemical compounds that act as partial agonists on 5-HT receptors, with DOM being hallucinogenic and lisuride lacking these properties.
  • A study using electrophysiological techniques on rats found that both drugs increased theta power and oscillation frequency but differed in their effects on medium spiny neurons and fast-spiking interneurons.
  • These findings highlight similarities that may help explain their effects on behavior, while also pointing out critical differences in neuronal activity that could account for the distinct hallucinogenic effects of DOM compared to the non-hallucinogenic lisuride.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!